Examples of NaSSAs include:
NaSSAs are said to have fewer side effects than tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) while being equally effective. In particular, it is said that the sexual dysfunction that is a relatively common side effect of SSRIs occurs significantly less often during treatment with Mirtazapine.
Wipo Publishes Patent of Yutoku Pharmaceutical Industries for "Noradrenergic and Specific Serotonergic Antidepressant-Containing Transdermal Patch" (Japanese, Swedish Inventors)
Aug 07, 2012; GENEVA, Aug. 7 -- Publication No. WO/2012/077651 was published on June 14. Title of the invention: "NORADRENERGIC AND SPECIFIC...
Efficacy and Tolerability of Antidepressants for Treatment of Depression in Coronary Artery Disease: A Meta-Analysis
Feb 01, 2010; Objective: Depression occurs in 18% to 45% of patients with coronary artery disease (CAD) where it is associated with an...